Page last updated: 2024-10-25

cimetidine and Hospital-Acquired Condition

cimetidine has been researched along with Hospital-Acquired Condition in 2 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wormsley, KG1
Lee, CH1
P'eng, FK1
Lui, WY1

Other Studies

2 other studies available for cimetidine and Hospital-Acquired Condition

ArticleYear
Problems in the medical treatment of peptic ulcers.
    Journal of the Royal College of Physicians of London, 1980, Volume: 14, Issue:3

    Topics: Cimetidine; Endoscopy; Humans; Iatrogenic Disease; Pain Management; Peptic Ulcer; Recurrence

1980
The clinical aspect of retained gastric antrum.
    Archives of surgery (Chicago, Ill. : 1960), 1986, Volume: 121, Issue:10

    Topics: Adult; Aged; Cimetidine; Female; Follow-Up Studies; Gastrectomy; Gastric Juice; Humans; Iatrogenic D

1986